Breadcrumb
- Home
- Publications
- Proceedings
- 2025 AIChE Annual Meeting
- Pharmaceutical Discovery, Development and Manufacturing Forum
- Enabling Technologies Relevant to Drug Substance
- (94e) CHO Cell Culture Process Development Via Metabolic Modeling
Model-based process development was demonstrated via three experimentally validated case studies. First, the DMFA model was used to predict intensified fed-batch bioreactor performance by predicting the impacts of high bioreactor seeding density and bioreactor pH on the viably cell density and final mAb titers. The predictions of amino acid metabolism provided insights on depletion or accumulation of various amino acids. Thus, providing mechanistic information that is needed to rebalance media composition. Second, the metabolic model that was trained on only fed-batch data was used to predict the impact of perfusion bioreactor process parameters such as perfusion rate and bleed rate on viable cell density, mAb titers, and metabolite concentrations. Thus, demonstrating that existing fed-batch data can be leveraged to predict perfusion bioreactor performance. Finally, we evaluated the impact of AMBIC basal and feed media on cell culture performance. The model not only successfully predicted the cell culture performance but also provided valuable information on depletion of certain amino acids. This information can lead to improved media composition and feed media supplementation schedules.
References